Michael J. Paskow

1.3k total citations
20 papers, 592 citations indexed

About

Michael J. Paskow is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Michael J. Paskow has authored 20 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 6 papers in Hepatology and 5 papers in Oncology. Recurrent topics in Michael J. Paskow's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Sleep and related disorders (4 papers). Michael J. Paskow is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Sleep and related disorders (4 papers). Michael J. Paskow collaborates with scholars based in United States, Spain and Japan. Michael J. Paskow's co-authors include Cornelia M. Ulrich, Boris A. Brühmann, Karen Steindorf, Jenny Chang‐Claude, Erin M. Siegel, Jennifer Ose, Stephanie Skender, Max Hirshkowitz, Anita Roach and D. Sunshine Hillygus and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemistry and Annals of Oncology.

In The Last Decade

Michael J. Paskow

20 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Paskow United States 9 229 182 160 81 73 20 592
Christel Hedman Sweden 12 79 0.3× 187 1.0× 172 1.1× 90 1.1× 76 1.0× 38 624
Barbara M. Foster United States 12 49 0.2× 299 1.6× 129 0.8× 38 0.5× 26 0.4× 17 965
Sarah D. Mills United States 14 162 0.7× 92 0.5× 63 0.4× 111 1.4× 18 0.2× 50 640
Yonghai Dong China 8 68 0.3× 61 0.3× 90 0.6× 36 0.4× 34 0.5× 18 509
Aleksandra Kroemeke Poland 12 68 0.3× 61 0.3× 53 0.3× 50 0.6× 34 0.5× 36 362
Nancy F. Woods United States 10 88 0.4× 116 0.6× 72 0.5× 58 0.7× 52 0.7× 15 510
Katarzyna Nowicka‐Sauer Poland 13 44 0.2× 86 0.5× 66 0.4× 116 1.4× 57 0.8× 51 560
Amanda Stone United States 20 116 0.5× 103 0.6× 26 0.2× 64 0.8× 64 0.9× 61 1.1k
Débora Rosa Italy 13 101 0.4× 113 0.6× 114 0.7× 265 3.3× 55 0.8× 46 633

Countries citing papers authored by Michael J. Paskow

Since Specialization
Citations

This map shows the geographic impact of Michael J. Paskow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Paskow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Paskow more than expected).

Fields of papers citing papers by Michael J. Paskow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Paskow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Paskow. The network helps show where Michael J. Paskow may publish in the future.

Co-authorship network of co-authors of Michael J. Paskow

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Paskow. A scholar is included among the top collaborators of Michael J. Paskow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Paskow. Michael J. Paskow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rimassa, Lorenza, Farshid Dayyani, Bruno Sangro, et al.. (2024). 169P Outcomes by comorbidities (CMs) with tremelimumab (T) and durvalumab (D) in the phase III HIMALAYA study in unresectable hepatocellular carcinoma (uHCC). Annals of Oncology. 35. S77–S78. 1 indexed citations
3.
Reig, María, Vincent C. Tam, Isabelle Archambeaud, et al.. (2024). 167P Non-viral aetiology subgroup of the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC). Annals of Oncology. 35. S75–S76. 1 indexed citations
4.
Bridgewater, John, Ágota Szende, Michael J. Paskow, et al.. (2024). Real-world treatment patterns and challenges of patients with biliary tract cancer: retrospective chart review survey in Europe (GARNET-2). SHILAP Revista de lepidopterología. 5. 100060–100060. 2 indexed citations
6.
Paskow, Michael J., et al.. (2024). Patient Experience of Hepatocellular Carcinoma and Their Treatment Goals: An International Qualitative Study and Patient Journey Map. Advances in Therapy. 41(9). 3598–3614. 2 indexed citations
7.
9.
Bridgewater, John, et al.. (2023). 125P Real-world treatment patterns in patients with biliary tract cancer (BTC): Retrospective chart review survey in Europe (GARNET-2). Annals of Oncology. 34. S229–S230. 1 indexed citations
10.
Monk, Bradley J., et al.. (2022). Proportions and incidence of locally advanced cervical cancer: a global systematic literature review. International Journal of Gynecological Cancer. 32(12). 1531–1539. 35 indexed citations
11.
Pujade-Lauraine, Éric, David S.P. Tan, Alexandra Léary, et al.. (2022). Comparison of global treatment guidelines for locally advanced cervical cancer to optimize best care practices: A systematic and scoping review. Gynecologic Oncology. 167(2). 360–372. 11 indexed citations
12.
Ohayon, Maurice M., Michael J. Paskow, Anita Roach, et al.. (2018). The National Sleep Foundation's Sleep Satisfaction Tool. Sleep Health. 5(1). 5–11. 29 indexed citations
13.
Ohayon, Maurice M., Michael C. Chen, Edward O. Bixler, et al.. (2017). A provisional tool for the measurement of sleep satisfaction. Sleep Health. 4(1). 6–12. 21 indexed citations
14.
Knutson, Kristen L., Julie E. Phelan, Michael J. Paskow, et al.. (2017). The National Sleep Foundation's Sleep Health Index. Sleep Health. 3(4). 234–240. 129 indexed citations
15.
Phelan, Jo C., Michael J. Paskow, Anita Roach, et al.. (2017). 0771 THE NATIONAL SLEEP FOUNDATION’S SLEEP HEALTH INDEX. SLEEP. 40(suppl_1). A286–A286. 5 indexed citations
16.
Boehm, Juergen, Dominique Scherer, Michael J. Paskow, et al.. (2016). CT-based compartmental quantification of adipose tissue versus body metrics in colorectal cancer patients. European Radiology. 26(11). 4131–4140. 31 indexed citations
17.
Skender, Stephanie, Jennifer Ose, Jenny Chang‐Claude, et al.. (2016). Accelerometry and physical activity questionnaires - a systematic review. BMC Public Health. 16(1). 515–515. 275 indexed citations
18.
Schrotz‐King, Petra, Michael J. Paskow, Katharina Buck, et al.. (2012). Abstract 81: Dietary supplement use among German colorectal cancer patients: The ColoCare Study.. Cancer Epidemiology Biomarkers & Prevention. 21(11_Supplement). 81–81. 1 indexed citations
19.
Childs, Lauren M., Michael J. Paskow, Sidney M. Morris, Matthias Hesse, & Steven H. Strogatz. (2011). From Inflammation to Wound Healing: Using a Simple Model to Understand the Functional Versatility of Murine Macrophages. Bulletin of Mathematical Biology. 73(11). 2575–2604. 5 indexed citations
20.
Li, Zhi, Janet Mans, Michael J. Paskow, et al.. (2010). Direct Interaction of the Mouse Cytomegalovirus m152/gp40 Immunoevasin with RAE-1 Isoforms. Biochemistry. 49(11). 2443–2453. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026